Hepatitis C Main Section
FDA-approved Monotherapies
FDA-approved Combination Therapies
Intron A
Roferon

Infergen
Pegasys
PEG-Intron
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Link to Hepatitis C Main Section

HCV - Diabetes / Diabetes Mellitus

Community-based Study in Taiwan Provides More Evidence of Link between Hepatitis C and Type 2 Diabetes    - 8/17/07

Diabetes Treatment
May Improve Response to Pegylated Interferon/Ribavirin, and HCV Eradication in Turn May Reduce Insulin Resistance    - 6/19/07

Hepatitis C Viremia, but Not Hepatitis B, Is Associated with Increased Diabetes Risk    - 7/17/07

Diabetes Is a Risk Factor for Liver Cancer Recurrence after Surgery in Patients with Viral Hepatitis    - 7/13/07


Diabetes
is Associated with Hepatic Encephalopathy in Patients with HCV-Related Cirrhosis- 8/18/06


Diabetes Mellitus
Is More Frequent in Patients with Hepatitis C- Than in Hepatitis B-related Cirrhosis - 10/28/05